GB201012660D0 - Inhaler and formulation - Google Patents

Inhaler and formulation

Info

Publication number
GB201012660D0
GB201012660D0 GBGB1012660.5A GB201012660A GB201012660D0 GB 201012660 D0 GB201012660 D0 GB 201012660D0 GB 201012660 A GB201012660 A GB 201012660A GB 201012660 D0 GB201012660 D0 GB 201012660D0
Authority
GB
United Kingdom
Prior art keywords
inhaler
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1012660.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to GBGB1012660.5A priority Critical patent/GB201012660D0/en
Publication of GB201012660D0 publication Critical patent/GB201012660D0/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
GBGB1012660.5A 2010-07-28 2010-07-28 Inhaler and formulation Ceased GB201012660D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1012660.5A GB201012660D0 (en) 2010-07-28 2010-07-28 Inhaler and formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1012660.5A GB201012660D0 (en) 2010-07-28 2010-07-28 Inhaler and formulation

Publications (1)

Publication Number Publication Date
GB201012660D0 true GB201012660D0 (en) 2010-09-15

Family

ID=42799224

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1012660.5A Ceased GB201012660D0 (en) 2010-07-28 2010-07-28 Inhaler and formulation

Country Status (1)

Country Link
GB (1) GB201012660D0 (en)

Similar Documents

Publication Publication Date Title
HUS2100032I1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
HK1187049A1 (en) Bisaryl-bonded aryltriazolones and use thereof
GB2484244B (en) Anaesthetic formulation
EP2542086A4 (en) Compounds and therapeutic uses thereof
RS55446B1 (en) Inhalator
GB201010193D0 (en) Medicinal use
ZA201208173B (en) Peptices and their use
SI2605757T1 (en) Nalbuphine-based formulations and uses thereof
IL221768A (en) Inhalator
PT2521445T (en) Formulation and use thereof
EP2608785A4 (en) Lipomacrocycles and uses thereof
PT2563806E (en) Human leukolectins and uses thereof
EP2529013A4 (en) Novel -glucosidase and uses thereof
EP2615094A4 (en) Sesterterpene compounds and use thereof
GB201012660D0 (en) Inhaler and formulation
EP2657236A4 (en) Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
EP2638160A4 (en) Nuclions and ribocapsids
GB201002451D0 (en) Pharmaceutical comopitions and devices
GB201001383D0 (en) New compounds and medical uses
GB201001376D0 (en) New compounds and medical uses
GB201001370D0 (en) New compounds and medical uses
GB201001364D0 (en) New compounds and medical uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)